CDP-L-ribitol pyrophosphorylase A
| UniProt | Protein Name |
|---|---|
| A4D126 |
|
| A0A140VJM1 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| axon guidance | ||
| isoprenoid biosynthetic process | ||
| protein O-linked mannosylation | ||
| protein O-linked mannosylation |
| GO Term | Evidence Code | PMID |
|---|---|---|
| protein homodimerization activity | ||
| D-ribitol-5-phosphate cytidylyltransferase activity | ||
| D-ribitol-5-phosphate cytidylyltransferase activity | ||
| cytidylyltransferase activity |
| Gene Ontology |
|---|
| catalytic activity |
| cytidylyltransferase activity |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110295 | autosomal recessive limb-girdle muscular dystrophy type 2U | |
| DOID:0111234 | congenital muscular dystrophy-dystroglycanopathy type A7 |
| HPO ID | HPO Term |
|---|---|
| HP:0008981 | Calf muscle hypertrophy |
| HP:0008994 | Proximal muscle weakness in lower limbs |
| HP:0008997 | Proximal muscle weakness in upper limbs |
| HP:0010508 | Metatarsus valgus |
| HP:0011446 | Abnormality of mental function |
| HP:0011463 | Childhood onset |
| HP:0012400 | Abnormal circulating aldolase concentration |
| HP:0012548 | Fatty replacement of skeletal muscle |
| HP:0100022 | Abnormality of movement |
| HP:0100543 | Cognitive impairment |
| Disease ID | Disease Name |
|---|---|
| ORPHA:370980 |
|
| ORPHA:899 |
|
| OMIM:614643 |
|
| OMIM:616052 |
|
| ORPHA:588 |
|
| ORPHA:352479 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026